Organogenesis Holdings Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Organogenesis Holdings Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q4 2024.
  • Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $2.58M.
  • Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$3.67M, a 167% decline year-over-year.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2024 was -$3.67M, a 167% decline from 2023.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2023 was $5.45M, a 14.7% increase from 2022.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2022 was $4.75M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$3.67M $2.58M +$3.81M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$7.48M -$6.51M -$11M -246% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.5M $2.5M -$1.36M -35.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.86M -$2.24M -$585K -35.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.45M -$1.23M -$2.5M -197% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $7.94M $4.47M +$3.47M +348% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $4.47M $3.86M +$1.42M +58.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $3.05M -$1.66M -$1.7M -3784% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $4.75M $1.27M +$33.4M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$28.6M $997K +$694K +229% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$29.3M $2.44M +$1.95M +401% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$31.3M $45K -$155K -77.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$31.1M -$32.1M -$32.5M -8208% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $1.39M $303K +$231K +321% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.16M $487K +$460K +1704% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $695K $200K +$165K +471% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $530K $396K +$354K +843% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $176K $72K +$24K +50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $152K $27K +$4K +17.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $148K $35K -$2K -5.41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $150K $42K +$40K +2000% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $110K $48K +$21K +77.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $89K $23K -$4K -14.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $93K $37K +$9K +32.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $84K $2K +$235K Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$151K $27K -$20K -42.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$131K $27K +$183K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$314K $28K +$6.71M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$7.03M -$233K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $47K Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$156K Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$6.68M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.